0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Ablation Therapy Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-4J13580
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Ablation Therapy Market Research Report 2023
BUY CHAPTERS

Global Tumor Ablation Therapy Market Research Report 2024

Code: QYRE-Auto-4J13580
Report
May 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tumor Ablation Therapy Market Size

The global Tumor Ablation Therapy market was valued at US$ 537 million in 2023 and is anticipated to reach US$ 658.5 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.

Tumor Ablation Therapy Market

Tumor Ablation Therapy Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Tumor Ablation Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Ablation Therapy.

Report Scope

The Tumor Ablation Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Ablation Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Ablation Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Ablation Therapy Market Report

Report Metric Details
Report Name Tumor Ablation Therapy Market
Accounted market size in 2023 US$ 537 million
Forecasted market size in 2030 US$ 658.5 million
CAGR 3.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Cold Ablation
Segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific, Smith and Nephew, VISON Medical, Nanjing MICRO-TECH, TIPC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tumor Ablation Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tumor Ablation Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Tumor Ablation Therapy Market growing?

Ans: The Tumor Ablation Therapy Market witnessing a CAGR of 3.0% during the forecast period 2024-2030.

What is the Tumor Ablation Therapy Market size in 2030?

Ans: The Tumor Ablation Therapy Market size in 2030 will be US$ 658.5 million.

Who are the main players in the Tumor Ablation Therapy Market report?

Ans: The main players in the Tumor Ablation Therapy Market are Medtronic, Olympus, LungCare, Broncus, Intuitive Surgica, Auris Health, Angiodynamics, Boston Scientific, Smith and Nephew, VISON Medical, Nanjing MICRO-TECH, TIPC

What are the Application segmentation covered in the Tumor Ablation Therapy Market report?

Ans: The Applications covered in the Tumor Ablation Therapy Market report are Hospitals, Ambulatory Surgical Centers

What are the Type segmentation covered in the Tumor Ablation Therapy Market report?

Ans: The Types covered in the Tumor Ablation Therapy Market report are Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cold Ablation

1 Tumor Ablation Therapy Market Overview
1.1 Product Overview and Scope of Tumor Ablation Therapy
1.2 Tumor Ablation Therapy Segment by Type
1.2.1 Global Tumor Ablation Therapy Market Value Comparison by Type (2024-2030)
1.2.2 Radiofrequency Ablation (RFA)
1.2.3 Microwave Ablation (MWA)
1.2.4 Cold Ablation
1.3 Tumor Ablation Therapy Segment by Application
1.3.1 Global Tumor Ablation Therapy Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Global Tumor Ablation Therapy Market Size Estimates and Forecasts
1.4.1 Global Tumor Ablation Therapy Revenue 2019-2030
1.4.2 Global Tumor Ablation Therapy Sales 2019-2030
1.4.3 Global Tumor Ablation Therapy Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tumor Ablation Therapy Market Competition by Manufacturers
2.1 Global Tumor Ablation Therapy Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tumor Ablation Therapy Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tumor Ablation Therapy Average Price by Manufacturers (2019-2024)
2.4 Global Tumor Ablation Therapy Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Ablation Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Ablation Therapy, Product Type & Application
2.7 Tumor Ablation Therapy Market Competitive Situation and Trends
2.7.1 Tumor Ablation Therapy Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Tumor Ablation Therapy Players Market Share by Revenue
2.7.3 Global Tumor Ablation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tumor Ablation Therapy Retrospective Market Scenario by Region
3.1 Global Tumor Ablation Therapy Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tumor Ablation Therapy Global Tumor Ablation Therapy Sales by Region: 2019-2030
3.2.1 Global Tumor Ablation Therapy Sales by Region: 2019-2024
3.2.2 Global Tumor Ablation Therapy Sales by Region: 2025-2030
3.3 Global Tumor Ablation Therapy Global Tumor Ablation Therapy Revenue by Region: 2019-2030
3.3.1 Global Tumor Ablation Therapy Revenue by Region: 2019-2024
3.3.2 Global Tumor Ablation Therapy Revenue by Region: 2025-2030
3.4 North America Tumor Ablation Therapy Market Facts & Figures by Country
3.4.1 North America Tumor Ablation Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tumor Ablation Therapy Sales by Country (2019-2030)
3.4.3 North America Tumor Ablation Therapy Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tumor Ablation Therapy Market Facts & Figures by Country
3.5.1 Europe Tumor Ablation Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tumor Ablation Therapy Sales by Country (2019-2030)
3.5.3 Europe Tumor Ablation Therapy Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Ablation Therapy Market Facts & Figures by Country
3.6.1 Asia Pacific Tumor Ablation Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tumor Ablation Therapy Sales by Country (2019-2030)
3.6.3 Asia Pacific Tumor Ablation Therapy Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tumor Ablation Therapy Market Facts & Figures by Country
3.7.1 Latin America Tumor Ablation Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tumor Ablation Therapy Sales by Country (2019-2030)
3.7.3 Latin America Tumor Ablation Therapy Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Ablation Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Ablation Therapy Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tumor Ablation Therapy Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tumor Ablation Therapy Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tumor Ablation Therapy Sales by Type (2019-2030)
4.1.1 Global Tumor Ablation Therapy Sales by Type (2019-2024)
4.1.2 Global Tumor Ablation Therapy Sales by Type (2025-2030)
4.1.3 Global Tumor Ablation Therapy Sales Market Share by Type (2019-2030)
4.2 Global Tumor Ablation Therapy Revenue by Type (2019-2030)
4.2.1 Global Tumor Ablation Therapy Revenue by Type (2019-2024)
4.2.2 Global Tumor Ablation Therapy Revenue by Type (2025-2030)
4.2.3 Global Tumor Ablation Therapy Revenue Market Share by Type (2019-2030)
4.3 Global Tumor Ablation Therapy Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tumor Ablation Therapy Sales by Application (2019-2030)
5.1.1 Global Tumor Ablation Therapy Sales by Application (2019-2024)
5.1.2 Global Tumor Ablation Therapy Sales by Application (2025-2030)
5.1.3 Global Tumor Ablation Therapy Sales Market Share by Application (2019-2030)
5.2 Global Tumor Ablation Therapy Revenue by Application (2019-2030)
5.2.1 Global Tumor Ablation Therapy Revenue by Application (2019-2024)
5.2.2 Global Tumor Ablation Therapy Revenue by Application (2025-2030)
5.2.3 Global Tumor Ablation Therapy Revenue Market Share by Application (2019-2030)
5.3 Global Tumor Ablation Therapy Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Tumor Ablation Therapy Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Olympus
6.2.1 Olympus Corporation Information
6.2.2 Olympus Description and Business Overview
6.2.3 Olympus Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Olympus Tumor Ablation Therapy Product Portfolio
6.2.5 Olympus Recent Developments/Updates
6.3 LungCare
6.3.1 LungCare Corporation Information
6.3.2 LungCare Description and Business Overview
6.3.3 LungCare Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.3.4 LungCare Tumor Ablation Therapy Product Portfolio
6.3.5 LungCare Recent Developments/Updates
6.4 Broncus
6.4.1 Broncus Corporation Information
6.4.2 Broncus Description and Business Overview
6.4.3 Broncus Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Broncus Tumor Ablation Therapy Product Portfolio
6.4.5 Broncus Recent Developments/Updates
6.5 Intuitive Surgica
6.5.1 Intuitive Surgica Corporation Information
6.5.2 Intuitive Surgica Description and Business Overview
6.5.3 Intuitive Surgica Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Intuitive Surgica Tumor Ablation Therapy Product Portfolio
6.5.5 Intuitive Surgica Recent Developments/Updates
6.6 Auris Health
6.6.1 Auris Health Corporation Information
6.6.2 Auris Health Description and Business Overview
6.6.3 Auris Health Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Auris Health Tumor Ablation Therapy Product Portfolio
6.6.5 Auris Health Recent Developments/Updates
6.7 Angiodynamics
6.6.1 Angiodynamics Corporation Information
6.6.2 Angiodynamics Description and Business Overview
6.6.3 Angiodynamics Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Angiodynamics Tumor Ablation Therapy Product Portfolio
6.7.5 Angiodynamics Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boston Scientific Tumor Ablation Therapy Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 Smith and Nephew
6.9.1 Smith and Nephew Corporation Information
6.9.2 Smith and Nephew Description and Business Overview
6.9.3 Smith and Nephew Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Smith and Nephew Tumor Ablation Therapy Product Portfolio
6.9.5 Smith and Nephew Recent Developments/Updates
6.10 VISON Medical
6.10.1 VISON Medical Corporation Information
6.10.2 VISON Medical Description and Business Overview
6.10.3 VISON Medical Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.10.4 VISON Medical Tumor Ablation Therapy Product Portfolio
6.10.5 VISON Medical Recent Developments/Updates
6.11 Nanjing MICRO-TECH
6.11.1 Nanjing MICRO-TECH Corporation Information
6.11.2 Nanjing MICRO-TECH Tumor Ablation Therapy Description and Business Overview
6.11.3 Nanjing MICRO-TECH Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nanjing MICRO-TECH Tumor Ablation Therapy Product Portfolio
6.11.5 Nanjing MICRO-TECH Recent Developments/Updates
6.12 TIPC
6.12.1 TIPC Corporation Information
6.12.2 TIPC Tumor Ablation Therapy Description and Business Overview
6.12.3 TIPC Tumor Ablation Therapy Sales, Revenue and Gross Margin (2019-2024)
6.12.4 TIPC Tumor Ablation Therapy Product Portfolio
6.12.5 TIPC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Ablation Therapy Industry Chain Analysis
7.2 Tumor Ablation Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Ablation Therapy Production Mode & Process
7.4 Tumor Ablation Therapy Sales and Marketing
7.4.1 Tumor Ablation Therapy Sales Channels
7.4.2 Tumor Ablation Therapy Distributors
7.5 Tumor Ablation Therapy Customers
8 Tumor Ablation Therapy Market Dynamics
8.1 Tumor Ablation Therapy Industry Trends
8.2 Tumor Ablation Therapy Market Drivers
8.3 Tumor Ablation Therapy Market Challenges
8.4 Tumor Ablation Therapy Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Tumor Ablation Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Tumor Ablation Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Tumor Ablation Therapy Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Tumor Ablation Therapy Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Tumor Ablation Therapy Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Tumor Ablation Therapy Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Tumor Ablation Therapy Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Tumor Ablation Therapy Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Tumor Ablation Therapy, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Tumor Ablation Therapy, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Tumor Ablation Therapy, Product Type & Application
    Table 12. Global Key Manufacturers of Tumor Ablation Therapy, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Tumor Ablation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Ablation Therapy as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tumor Ablation Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Tumor Ablation Therapy Sales by Region (2019-2024) & (K Units)
    Table 18. Global Tumor Ablation Therapy Sales Market Share by Region (2019-2024)
    Table 19. Global Tumor Ablation Therapy Sales by Region (2025-2030) & (K Units)
    Table 20. Global Tumor Ablation Therapy Sales Market Share by Region (2025-2030)
    Table 21. Global Tumor Ablation Therapy Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Tumor Ablation Therapy Revenue Market Share by Region (2019-2024)
    Table 23. Global Tumor Ablation Therapy Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Tumor Ablation Therapy Revenue Market Share by Region (2025-2030)
    Table 25. North America Tumor Ablation Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Tumor Ablation Therapy Sales by Country (2019-2024) & (K Units)
    Table 27. North America Tumor Ablation Therapy Sales by Country (2025-2030) & (K Units)
    Table 28. North America Tumor Ablation Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Tumor Ablation Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Tumor Ablation Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Tumor Ablation Therapy Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Tumor Ablation Therapy Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Tumor Ablation Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Tumor Ablation Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Tumor Ablation Therapy Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Tumor Ablation Therapy Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Tumor Ablation Therapy Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Tumor Ablation Therapy Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Tumor Ablation Therapy Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Tumor Ablation Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Tumor Ablation Therapy Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Tumor Ablation Therapy Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Tumor Ablation Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Tumor Ablation Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Tumor Ablation Therapy Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Tumor Ablation Therapy Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Tumor Ablation Therapy Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Tumor Ablation Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Tumor Ablation Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Tumor Ablation Therapy Sales (K Units) by Type (2019-2024)
    Table 51. Global Tumor Ablation Therapy Sales (K Units) by Type (2025-2030)
    Table 52. Global Tumor Ablation Therapy Sales Market Share by Type (2019-2024)
    Table 53. Global Tumor Ablation Therapy Sales Market Share by Type (2025-2030)
    Table 54. Global Tumor Ablation Therapy Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Tumor Ablation Therapy Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Tumor Ablation Therapy Revenue Market Share by Type (2019-2024)
    Table 57. Global Tumor Ablation Therapy Revenue Market Share by Type (2025-2030)
    Table 58. Global Tumor Ablation Therapy Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Tumor Ablation Therapy Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Tumor Ablation Therapy Sales (K Units) by Application (2019-2024)
    Table 61. Global Tumor Ablation Therapy Sales (K Units) by Application (2025-2030)
    Table 62. Global Tumor Ablation Therapy Sales Market Share by Application (2019-2024)
    Table 63. Global Tumor Ablation Therapy Sales Market Share by Application (2025-2030)
    Table 64. Global Tumor Ablation Therapy Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Tumor Ablation Therapy Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Tumor Ablation Therapy Revenue Market Share by Application (2019-2024)
    Table 67. Global Tumor Ablation Therapy Revenue Market Share by Application (2025-2030)
    Table 68. Global Tumor Ablation Therapy Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Tumor Ablation Therapy Price (US$/Unit) by Application (2025-2030)
    Table 70. Medtronic Corporation Information
    Table 71. Medtronic Description and Business Overview
    Table 72. Medtronic Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Medtronic Tumor Ablation Therapy Product
    Table 74. Medtronic Recent Developments/Updates
    Table 75. Olympus Corporation Information
    Table 76. Olympus Description and Business Overview
    Table 77. Olympus Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Olympus Tumor Ablation Therapy Product
    Table 79. Olympus Recent Developments/Updates
    Table 80. LungCare Corporation Information
    Table 81. LungCare Description and Business Overview
    Table 82. LungCare Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. LungCare Tumor Ablation Therapy Product
    Table 84. LungCare Recent Developments/Updates
    Table 85. Broncus Corporation Information
    Table 86. Broncus Description and Business Overview
    Table 87. Broncus Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Broncus Tumor Ablation Therapy Product
    Table 89. Broncus Recent Developments/Updates
    Table 90. Intuitive Surgica Corporation Information
    Table 91. Intuitive Surgica Description and Business Overview
    Table 92. Intuitive Surgica Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Intuitive Surgica Tumor Ablation Therapy Product
    Table 94. Intuitive Surgica Recent Developments/Updates
    Table 95. Auris Health Corporation Information
    Table 96. Auris Health Description and Business Overview
    Table 97. Auris Health Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Auris Health Tumor Ablation Therapy Product
    Table 99. Auris Health Recent Developments/Updates
    Table 100. Angiodynamics Corporation Information
    Table 101. Angiodynamics Description and Business Overview
    Table 102. Angiodynamics Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Angiodynamics Tumor Ablation Therapy Product
    Table 104. Angiodynamics Recent Developments/Updates
    Table 105. Boston Scientific Corporation Information
    Table 106. Boston Scientific Description and Business Overview
    Table 107. Boston Scientific Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. Boston Scientific Tumor Ablation Therapy Product
    Table 109. Boston Scientific Recent Developments/Updates
    Table 110. Smith and Nephew Corporation Information
    Table 111. Smith and Nephew Description and Business Overview
    Table 112. Smith and Nephew Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Smith and Nephew Tumor Ablation Therapy Product
    Table 114. Smith and Nephew Recent Developments/Updates
    Table 115. VISON Medical Corporation Information
    Table 116. VISON Medical Description and Business Overview
    Table 117. VISON Medical Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. VISON Medical Tumor Ablation Therapy Product
    Table 119. VISON Medical Recent Developments/Updates
    Table 120. Nanjing MICRO-TECH Corporation Information
    Table 121. Nanjing MICRO-TECH Description and Business Overview
    Table 122. Nanjing MICRO-TECH Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Nanjing MICRO-TECH Tumor Ablation Therapy Product
    Table 124. Nanjing MICRO-TECH Recent Developments/Updates
    Table 125. TIPC Corporation Information
    Table 126. TIPC Description and Business Overview
    Table 127. TIPC Tumor Ablation Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. TIPC Tumor Ablation Therapy Product
    Table 129. TIPC Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. Tumor Ablation Therapy Distributors List
    Table 133. Tumor Ablation Therapy Customers List
    Table 134. Tumor Ablation Therapy Market Trends
    Table 135. Tumor Ablation Therapy Market Drivers
    Table 136. Tumor Ablation Therapy Market Challenges
    Table 137. Tumor Ablation Therapy Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tumor Ablation Therapy
    Figure 2. Global Tumor Ablation Therapy Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Tumor Ablation Therapy Market Share by Type in 2023 & 2030
    Figure 4. Radiofrequency Ablation (RFA) Product Picture
    Figure 5. Microwave Ablation (MWA) Product Picture
    Figure 6. Cold Ablation Product Picture
    Figure 7. Global Tumor Ablation Therapy Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Tumor Ablation Therapy Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Ambulatory Surgical Centers
    Figure 11. Global Tumor Ablation Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Tumor Ablation Therapy Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Tumor Ablation Therapy Sales (2019-2030) & (K Units)
    Figure 14. Global Tumor Ablation Therapy Average Price (US$/Unit) & (2019-2030)
    Figure 15. Tumor Ablation Therapy Report Years Considered
    Figure 16. Tumor Ablation Therapy Sales Share by Manufacturers in 2023
    Figure 17. Global Tumor Ablation Therapy Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Tumor Ablation Therapy Players: Market Share by Revenue in 2023
    Figure 19. Tumor Ablation Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Tumor Ablation Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Tumor Ablation Therapy Sales Market Share by Country (2019-2030)
    Figure 22. North America Tumor Ablation Therapy Revenue Market Share by Country (2019-2030)
    Figure 23. United States Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Tumor Ablation Therapy Sales Market Share by Country (2019-2030)
    Figure 26. Europe Tumor Ablation Therapy Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Tumor Ablation Therapy Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Tumor Ablation Therapy Revenue Market Share by Region (2019-2030)
    Figure 34. China Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Tumor Ablation Therapy Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Tumor Ablation Therapy Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Tumor Ablation Therapy Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Tumor Ablation Therapy Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Tumor Ablation Therapy Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Tumor Ablation Therapy by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Tumor Ablation Therapy by Type (2019-2030)
    Figure 55. Global Tumor Ablation Therapy Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Tumor Ablation Therapy by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Tumor Ablation Therapy by Application (2019-2030)
    Figure 58. Global Tumor Ablation Therapy Price (US$/Unit) by Application (2019-2030)
    Figure 59. Tumor Ablation Therapy Value Chain
    Figure 60. Tumor Ablation Therapy Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart